| Catalog No. | 
			TD-HF697016 | 
		
		
			| Species reactivity | 
			Human | 
		
		
			| Applications | 
			Research Grade Biosimilar | 
		
		
			| Host species | 
			Humanized | 
		
		
			| Isotype | 
			Fab-G1-kappa | 
		
		
			| Expression system | 
			Mammalian Cells | 
		
		
			| Clonality | 
			Monoclonal | 
		
		
			| Target | 
			PFD, Adipsin, C3 convertase activator, Complement factor D, CFD, DF, Properdin factor D | 
		
		
			| Endotoxin level | 
			Please contact the lab for this information. | 
		
		
			| Purity | 
			>95% purity as determined by SDS-PAGE. | 
		
		
			| Purification | 
			Protein A/G, purified from cell culture supern atant. | 
		
		
			| Accession | 
			P00746 | 
		
		
			| Form | 
			Liquid | 
		
		
			| Storage buffer | 
			0.01M PBS,pH7.4. | 
		
		
			| Stability and Storage | 
			Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C. | 
		
		
			| Alternate Names | 
			AFD,Anti-fD,Anti-FACTORD,FCFD4514S,RG7417,CAS:1278466-20-8 | 
		
		
			| Background | 
			Lampalizumab (RG 7417) is a humanised monoclonal antibody targeting complement Factor D in the alternative complement pathway. Lampalizumab binds an exosite and sterically blocks Factor B access to the active site. Lampalizumab can be used for age-related macular degeneration (AMD) research. | 
		
		
			| Note | 
			For research use only. Not for use in clinical or therapeutic applications. |